WG Biotech ApS Financials, key figures and credit report
Gross profit -6 963.0 kDKK FY 2025 -115.4% vs 2024
EBIT -6 963.0 kDKK FY 2025 -115.4% vs 2024
Net debt -1.0 kDKK FY 2025 -100% vs 2024
Quick ratio 11 542.0 FY 2025 +11,535.2 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Change in stocks | - 302 239.00 | 48 641.00 | 45 273.00 | -6 849.00 | |
| External services | - 134.00 | -33.00 | - 142.00 | - 159.00 | - 114.00 |
| Gross profit | - 915 846.00 | - 302 272.00 | 48 499.00 | 45 114.00 | -6 963.00 |
| EBIT | - 915 846.00 | - 302 272.00 | 48 499.00 | 45 114.00 | -6 963.00 |
| Other financial income | 1 986.00 | 2 312.00 | 4 505.00 | 4 008.00 | 9 129.00 |
| Other financial expenses | - 273.00 | - 530.00 | - 588.00 | ||
| Reduction non-current investment assets | - 915 712.00 | ||||
| Pre-tax profit | - 913 860.00 | - 300 233.00 | 52 474.00 | 48 534.00 | 2 166.00 |
| Income taxes | 9 183.00 | -3 600.00 | |||
| Net earnings | - 913 860.00 | - 291 050.00 | 48 874.00 | 48 534.00 | 2 166.00 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Non-current loans receivable | 444 409.00 | 142 169.00 | 209 719.00 | 254 992.00 | |
| Long term receivables total | 444 409.00 | 142 169.00 | 209 719.00 | 254 992.00 | |
| Inventories total | |||||
| Current amounts owed by group member comp. | 66 568.00 | 69 879.00 | 63 493.00 | 63 743.00 | 311 634.00 |
| Short term receivables total | 66 568.00 | 69 879.00 | 63 493.00 | 63 743.00 | 311 634.00 |
| Cash and bank deposits | 4.00 | 3.00 | 8.00 | 1.00 | 1.00 |
| Cash and cash equivalents | 4.00 | 3.00 | 8.00 | 1.00 | 1.00 |
| Balance sheet total (assets) | 510 981.00 | 212 051.00 | 273 220.00 | 318 736.00 | 311 635.00 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 110.00 | 110.00 | 110.00 | 110.00 | 110.00 |
| Shares repurchased | 311 000.00 | ||||
| Retained earnings | 1 416 834.00 | 502 974.00 | 211 924.00 | 260 798.00 | -1 668.00 |
| Profit of the financial year | - 913 860.00 | - 291 050.00 | 48 874.00 | 48 534.00 | 2 166.00 |
| Shareholders equity total | 503 084.00 | 212 034.00 | 260 908.00 | 309 442.00 | 311 608.00 |
| Non-current liabilities total | |||||
| Current trade creditors | 14.00 | 16.00 | 26.00 | 26.00 | 27.00 |
| Current owed to group member | 7 883.00 | 12 286.00 | 9 268.00 | ||
| Other non-interest bearing current liabilities | 1.00 | ||||
| Current liabilities total | 7 897.00 | 17.00 | 12 312.00 | 9 294.00 | 27.00 |
| Balance sheet total (liabilities) | 510 981.00 | 212 051.00 | 273 220.00 | 318 736.00 | 311 635.00 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated